MedPath

Effectiveness of a low cost generic intervention to improve quality of life for people with psychosis

Not Applicable
Conditions
Health Condition 1: F20-F29- Schizophrenia, schizotypal, delusional, and other non-mood psychotic disorders
Registration Number
CTRI/2022/03/041005
Lead Sponsor
ational Institute for Health Research
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Diagnosis of psychosis

Aged over 18 years

Capacity for informed consent

Can speak and understand the local language

Has a low quality of life scoring less than 5 on the MANSA

for clinicians any professional background having regular contact with patients with psychosis

Exclusion Criteria

Dementia and or significant cognitive impairment and or severe learning disability

Organic psychosis or drug induced psychosis if given as the primary diagnosis

Unable to provide informed consent

clinicians who do not have regular contact with patients with psychosis and do not speak the local language

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath